Preparing for phase I unit regulatory inspections
Sudheendra K
Ashish A Mungantiwar
Muneesh Garg, Raghu Naidu, Amolkumar Birhade, Krishnan Iyer1, Ratnakar Jadhav Juliet Rebello, Nazma Morde, Mayuri Mangale and Bill Brashier
Nadin Almosnid and Elliot Altman
Fabrication of optimized Diclofenac potassium micro-particles using response surface methodology
Barkat Ali Khan
Bioequivalence of two prolonged release Diclofenac sodium formulations in healthy volunteers
Alejandro Saul Padron Yaquis, Daise Jimenez Rodriguez, Carlos Alberto Gonzalez Delgado, Dunia Cazanave Guarnaluce, Pedro Lazaro Alejo Cisneros, Tatiana Festary Casanovas, Maydel Barrios Sarmiento, Alina Diaz Machado, Sonia Perez Rodriguez, Alis Martin Trujillo, Laura Barrero Viera and Idrian Garci
Andras Fodor
Andras Fodor
Assessment of bioequivalence of respiratory dosage forms
Ashish A Mungantiwar
Strategy for successful regulatory inspections in a phase I human pharmacology unit
Sudheendra Kulkarni
Muneesh Garg, Raghu Naidu, Krishnan Iyer, Ratnakar Jadhav, Amolkumar Birhade1 Juliet Rebello, Nazma Morde and Bill Brashier
Biopharmaceutics of cancer: Drug delivery systems to maximize efficiency of anti-cancer drugs
Raja Mohamed
Journal of Bioanalysis & Biomedicine received 3099 citations as per Google Scholar report